1. Medtech Insight
  2. >>Policy & Regulation

CMS Proposes To Deny Most HCPCS Code Requests For DMEPOS Items

CMS met this week, and will again on June 3, to hear arguments in support of establishing new or revised level II HCPCS codes for 33 different durable medical equipment, prosthetics and orthotics items and medical supplies. But in preliminary rulings the agency signaled plans to deny all but two of the requests.

CMS is proposing to deny most requests for new or revised level II Healthcare Common Procedure Coding System reimbursement codes in 2015.

Of the 33 separate durable medical equipment, prosthetics and orthotics items, as well as medical supplies, that are the subject of code requests, the agency has only signaled interest in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

Cardiosense Advances Noninvasive Heart Monitoring With Final Validation Study

 
• By Marion Webb

Cardiosense has launched a nationwide clinical study, SEISMIC-HF II, to validate its non-invasive, AI-powered technology for monitoring heart failure. The data will be used to file for US regulatory clearance of the Cardiosense heart failure monitoring platform.

ConcertAI Launches Generative AI-Powered Precision Suite

 
• By Natasha Barrow

Valued at over $1.9bn, ConcertAI is building on its pre-existing multi-agentic AI SaaS solution CARAai to bring life science customers the new Precision suite of applications: Precision Explorer, Precision Trials, Precision GTM and Precision360.

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 
• By Amanda Maxwell

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.